drugset / Trial / NCT04705480

Pregabalin vs. Gabapentin on Reducing Opioid Usage

NCT04705480 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

This is a single-center, randomized, open-label, Phase 4 clinical trial investigating the efficacy of multiple-dose administrations of Pregabalin or Gabapentin in combination with traditional opioid pain medications to decrease the amount of opioid pain medication usage in single-system orthopedic trauma patients.

Timeline

Start
2021-04-12
Primary completion
2024-09-30
Completion
2024-12-13

Outcome

Missed primary endpoint

registry analysis (other test); Pregabalin vs Neither Pregabalin Nor Gabapentin; p = 0.557; Wilcoxon (Mann-Whitney) NCT04705480 ↗

registry analysis (other test); Gabapentin vs Neither Pregabalin Nor Gabapentin; p = 0.601; ANCOVA NCT04705480 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Unknown 300 mg Oral
Subject Pregabalin Small molecule 50 mg —

Indications

No indication recorded.